ID: ALA186192
Chembl Id: CHEMBL186192
PubChem CID: 44393462
Max Phase: Preclinical
Molecular Formula: C23H29F3O6
Molecular Weight: 458.47
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)CCCC/C=C\C[C@H]1[C@@H](O)CO[C@@H]1/C=C/[C@@H](O)COc1cccc(C(F)(F)F)c1
Standard InChI: InChI=1S/C23H29F3O6/c24-23(25,26)16-7-6-8-18(13-16)31-14-17(27)11-12-21-19(20(28)15-32-21)9-4-2-1-3-5-10-22(29)30/h2,4,6-8,11-13,17,19-21,27-28H,1,3,5,9-10,14-15H2,(H,29,30)/b4-2-,12-11+/t17-,19+,20+,21-/m1/s1
Standard InChI Key: LZIPRNCBZWUUBX-WYULLOFSSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 458.47 | Molecular Weight (Monoisotopic): 458.1916 | AlogP: 3.97 | #Rotatable Bonds: 12 |
| Polar Surface Area: 96.22 | Molecular Species: ACID | HBA: 5 | HBD: 3 |
| #RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 4.66 | CX Basic pKa: ┄ | CX LogP: 3.77 | CX LogD: 1.10 |
| Aromatic Rings: 1 | Heavy Atoms: 32 | QED Weighted: 0.32 | Np Likeness Score: 0.85 |
| 1. Selliah RD, Hellberg MR, Sharif NA, McLaughlin MA, Williams GW, Scott DA, Earnest D, Haggard KS, Dean WD, Delgado P, Gaines MS, Conrow RE, Klimko PG.. (2004) AL-12182, a novel 11-oxa prostaglandin analog with topical ocular hypotensive activity in the monkey., 14 (17): [PMID:15357985] [10.1016/j.bmcl.2004.06.037] |
Source(1):
